Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) announced its plan to release third quarter financial results on November 4, 2021, after market close. Management will hold a conference call at 4:30 p.m. ET to discuss the results. Insulet is known for its innovative Omnipod insulin management system, which offers a needle-free, wearable insulin delivery option. The company aims to simplify life for people with diabetes through its unique product platform. Investors can access the call via the company's Investor Relations website.

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced plans to release its financial results for the third quarter of 2021 on November 4, 2021 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

The link to the live call will be available on the Investor Relations section of the Company's website at investors.insulet.com, “Events and Presentations,” and will be archived for future replay. To participate in the live call via phone, please pre-register online here. You will then receive a telephone number and passcode required to enter the call.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005057/en/

Investor Relations:

Deborah R. Gordon

Vice President, Investor Relations

(978) 600-7717

dgordon@insulet.com

Merrill Robichaud

Investor Relations Coordinator

(978) 932-0444

mrobichaud@insulet.com

Media:

Angela Geryak Wiczek

Senior Director, Corporate Communications

(978) 932-0611

awiczek@insulet.com

Source: Insulet Corporation

FAQ

When will Insulet Corporation release its third quarter financial results?

Insulet Corporation will release its third quarter financial results on November 4, 2021, after the close of the financial markets.

What time is the conference call for Insulet's financial results?

The conference call for Insulet's financial results will be held at 4:30 p.m. ET on November 4, 2021.

Where can I find the link to Insulet's conference call?

The link to Insulet's conference call can be found on the Investor Relations section of their website.

What is Insulet Corporation known for?

Insulet Corporation is known for its Omnipod insulin management system, a tubeless insulin delivery device.